{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:09Z","timestamp":1707525129489},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,24]]},"DOI":"10.7759\/cureus.42382","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T15:56:35Z","timestamp":1690214195000},"source":"Crossref","is-referenced-by-count":0,"title":["Spinal Muscular Atrophy Type I With False Negative in Newborn Screening: A Case Report"],"prefix":"10.7759","author":[{"given":"Kazuhiko","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Yokokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Yuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Otsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre S","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, et al.. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995, 80:155-65. 10.1016\/0092-8674(95)90460-3","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072222","article-title":"New treatments in spinal muscular atrophy: positive results and new challenges","volume":"9","author":"Messina S","year":"2020","unstructured":"Messina S, Sframeli M. New treatments in spinal muscular atrophy: positive results and new challenges. J Clin Med. 2020, 9:10.3390\/jcm9072222","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2021.08.002","article-title":"Epidemiological investigation of spinal muscular atrophy in Japan","volume":"44","author":"Ito M","year":"2022","unstructured":"Ito M, Yamauchi A, Urano M, Kato T, Matsuo M, Nakashima K, Saito K. Epidemiological investigation of spinal muscular atrophy in Japan. Brain Dev. 2022, 44:2-16. 10.1016\/j.braindev.2021.08.002","journal-title":"Brain Dev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth B","year":"2006","unstructured":"Wirth B, Brichta L, Schrank B, Lochm\u00fcller H, Blick S, Baasner A, Heller R. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet. 2006, 119:422-8. 10.1007\/s00439-006-0156-7","journal-title":"Hum Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","volume":"28","author":"Calucho M","year":"2018","unstructured":"Calucho M, Bernal S, Al\u00edas L, et al.. Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Neuromuscul Disord. 2018, 28:208-15. 10.1016\/j.nmd.2018.01.003","journal-title":"Neuromuscul Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2022.100908","article-title":"Newborn screening for spinal muscular atrophy in Japan: one year of experience","volume":"32","author":"Sawada T","year":"2022","unstructured":"Sawada T, Kido J, Sugawara K, et al.. Newborn screening for spinal muscular atrophy in Japan: one year of experience. Mol Genet Metab Rep. 2022, 32:100908. 10.1016\/j.ymgmr.2022.100908","journal-title":"Mol Genet Metab Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99496-2","article-title":"Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium","volume":"11","author":"Boemer F","year":"2021","unstructured":"Boemer F, Caberg JH, Beckers P, et al.. Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium. Sci Rep. 2021, 11:19922. 10.1038\/s41598-021-99496-2","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijns7030033","article-title":"Landscape of spinal muscular atrophy newborn screening in the United States: 2018-2021","volume":"7","author":"Hale K","year":"2021","unstructured":"Hale K, Ojodu J, Singh S. Landscape of spinal muscular atrophy newborn screening in the United States: 2018-2021. Int J Neonatal Screen. 2021, 7:33. 10.3390\/ijns7030033","journal-title":"Int J Neonatal Screen"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2015.07.004","article-title":"Spinal muscular atrophy","volume":"33","author":"Kolb SJ","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015, 33:831-46. 10.1016\/j.ncl.2015.07.004","journal-title":"Neurol Clin"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2015.04.009","article-title":"209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7-9 November 2014, Heemskerk, The Netherlands","volume":"25","author":"Finkel R","year":"2015","unstructured":"Finkel R, Bertini E, Muntoni F, Mercuri E. 209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7-9 November 2014, Heemskerk, The Netherlands. Neuromuscul Disord. 2015, 25:593-602. 10.1016\/j.nmd.2015.04.009","journal-title":"Neuromuscul Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.06.042\/j.jpeds.2017.06.042","article-title":"Presymptomatic diagnosis of spinal muscular atrophy through newborn screening","volume":"190","author":"Chien YH","year":"2017","unstructured":"Chien YH, Chiang SC, Weng WC, et al.. Presymptomatic diagnosis of spinal muscular atrophy through newborn screening. J Pediatr. 2017, 190:124-129. 10.1016\/j.jpeds.2017.06.042\/j.jpeds.2017.06.042","journal-title":"J Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.152","article-title":"Pilot study of population-based newborn screening for spinal muscular atrophy in New York state","volume":"20","author":"Kraszewski JN","year":"2018","unstructured":"Kraszewski JN, Kay DM, Stevens CF, et al.. Pilot study of population-based newborn screening for spinal muscular atrophy in New York state. Genet Med. 2018, 20:608-13. 10.1038\/gim.2017.152","journal-title":"Genet Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-019-0476-4","article-title":"High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR","volume":"28","author":"Czibere L","year":"2020","unstructured":"Czibere L, Burggraf S, Fleige T, et al.. High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR. Eur J Hum Genet. 2020, 28:23-30. 10.1038\/s41431-019-0476-4","journal-title":"Eur J Hum Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijns5040041","article-title":"A novel system for spinal muscular atrophy screening in newborns: Japanese pilot study","volume":"5","author":"Shinohara M","year":"2019","unstructured":"Shinohara M, Niba ET, Wijaya YO, et al.. A novel system for spinal muscular atrophy screening in newborns: Japanese pilot study. Int J Neonatal Screen. 2019, 5:41. 10.3390\/ijns5040041","journal-title":"Int J Neonatal Screen"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/anc3.51519","article-title":"Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy","volume":"9","author":"D'Silva AM","year":"2022","unstructured":"D'Silva AM, Sandra H, Kariyawasam D, et al.. Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy. Ann Clin Transl Neurol. 2022, 9:339-50. 10.1002\/anc3.51519","journal-title":"Ann Clin Transl Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.15117","article-title":"Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme","volume":"64","author":"D'Silva AM","year":"2022","unstructured":"D'Silva AM, Kariyawasam DS, Best S, Wiley V, Farrar MA. Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme. Dev Med Child Neurol. 2022, 64:625-32. 10.1111\/dmcn.15117","journal-title":"Dev Med Child Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/genes13112110","article-title":"PCR-based screening of spinal muscular atrophy for newborn infants in Hyogo Prefecture, Japan","volume":"13","author":"Noguchi Y","year":"2022","unstructured":"Noguchi Y, Bo R, Nishio H, et al.. PCR-based screening of spinal muscular atrophy for newborn infants in Hyogo Prefecture, Japan. Genes (Basel). 2022, 13:2110-10. 10.3390\/genes13112110","journal-title":"Genes (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3233\/JND-221577","article-title":"Newbornscreening SMA - from pilot project to nationwide screening in Germany","volume":"10","author":"M\u00fcller-Felber W","year":"2023","unstructured":"M\u00fcller-Felber W, Blaschek A, Schwartz O, et al.. Newbornscreening SMA - from pilot project to nationwide screening in Germany. J Neuromuscul Dis. 2023, 10:55-65. 10.3233\/JND-221577","journal-title":"J Neuromuscul Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/170937-spinal-muscular-atrophy-type-i-with-false-negative-in-newborn-screening-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:30Z","timestamp":1707508890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/170937-spinal-muscular-atrophy-type-i-with-false-negative-in-newborn-screening-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.42382","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,24]]}}}